AAV1.NT3 Gene Therapy Mitigates the Severity of Autoimmune Encephalomyelitis in the Mouse Model for Multiple Sclerosis

scAAV1.tMCK.NT-3 was delivered to the gastrocnemius muscle of experimental autoimmune encephalomyelitis (EAE) mice, the chronic relapsing mouse model of multiple sclerosis, at three weeks post EAE induction.